QCG
LLY icon

Quadrant Capital Group’s Eli Lilly LLY Stock Holding History

Quadrant Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7M Buy
22,510
+748
+3% +$758K 0.62% 22
2025
Q4 		$23.4M Buy
21,762
+3,088
+17% +$2.95M 0.71% 20
2025
Q3 		$14.2M Buy
18,674
+362
+2% +$269K 0.46% 26
2025
Q2 		$14.3M Sell
18,312
-2,228
-11% -$1.73M 0.51% 26
2025
Q1 		$17M Buy
20,540
+10,183
+98% +$8.47M 0.63% 20
2024
Q4 		$8M Sell
10,357
-651
-6% -$539K 0.55% 24
2024
Q3 		$9.75M Sell
11,008
-175
-2% -$157K 0.68% 19
2024
Q2 		$10.1M Buy
11,183
+313
+3% +$250K 0.75% 17
2024
Q1 		$8.46M Buy
10,870
+245
+2% +$174K 0.67% 21
2023
Q4 		$6.19M Buy
10,625
+110
+1% +$64.2K 0.53% 27
2023
Q3 		$5.65M Buy
10,515
+897
+9% +$462K 0.57% 27
2023
Q2 		$4.51M Buy
9,618
+347
+4% +$146K 0.45% 34
2023
Q1 		$3.18M Buy
9,271
+499
+6% +$168K 0.33% 44
2022
Q4 		$3.21M Buy
8,772
+278
+3% +$98.6K 0.36% 41
2022
Q3 		$2.75M Buy
8,494
+472
+6% +$150K 0.36% 37
2022
Q2 		$2.6M Buy
8,022
+414
+5% +$124K 0.35% 46
2022
Q1 		$2.18M Buy
7,608
+477
+7% +$123K 0.26% 56
2021
Q4 		$1.97M Buy
7,131
+129
+2% +$32.7K 0.24% 65
2021
Q3 		$1.62M Buy
7,002
+26
+0.4% +$6.42K 0.23% 74
2021
Q2 		$1.6M Buy
6,976
+208
+3% +$41.8K 0.23% 69
2021
Q1 		$1.26M Buy
6,768
+588
+10% +$115K 0.21% 78
2020
Q4 		$1.04M Buy
6,180
+539
+10% +$80.5K 0.19% 85
2020
Q3 		$835K Sell
5,641
-223
-4% -$34.5K 0.18% 89
2020
Q2 		$963K Sell
5,864
-5,204
-47% -$799K 0.21% 81
2020
Q1 		$1.54M Buy
11,068
+3,432
+45% +$472K 0.26% 74
2019
Q4 		$979K Buy
7,636
+1,170
+18% +$136K 0.12% 128
2019
Q3 		$710K Buy
6,466
+2,351
+57% +$262K 0.11% 148
2019
Q2 		$442K Sell
4,115
-1,344
-25% -$158K 0.07% 261
2019
Q1 		$692K Buy
5,459
+2,056
+60% +$250K 0.12% 132
2018
Q4 		$380K Sell
3,403
-218
-6% -$24.4K 0.1% 166
2018
Q3 		$377K Buy
3,621
+72
+2% +$7.2K 0.11% 136
2018
Q2 		$290K Buy
3,549
+340
+11% +$27.9K 0.1% 163
2018
Q1 		$238K Sell
3,209
-17
-0.5% -$1.37K 0.09% 201
2017
Q4 		$262K Buy
3,226
+19
+0.6% +$1.62K 0.1% 169
2017
Q3 		$261K Buy
3,207
+182
+6% +$14.9K 0.11% 155
2017
Q2 		$212K Sell
3,025
-119
-4% -$9.71K 0.09% 176
2017
Q1 		$252K Sell
3,144
-87
-3% -$6.97K 0.11% 153
2016
Q4 		$229K Sell
3,231
-287
-8% -$21.4K 0.11% 131
2016
Q3 		$269K Buy
3,518
+81
+2% +$6.48K 0.18% 105
2016
Q2 		$258K Buy
3,437
+874
+34% +$65.8K 0.18% 100
2016
Q1 		$180K Buy
2,563
+198
+8% +$15K 0.12% 137
2015
Q4 		$195K Buy
2,365
+131
+6% +$10.9K 0.14% 138
2015
Q3 		$184K Sell
2,234
-5
-0.2% -$422 0.13% 133
2015
Q2 		$184K Buy
+2,239
New +$171K 0.12% 147

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Quadrant Capital Group's LLY Position: Q1 2026 in Review

Quadrant Capital Group increased its Eli Lilly (LLY) stake by 3.4% in Q1 2026, buying an estimated $758K and bringing the position to 22,510 shares worth $20.7M. The position accounts for 0.62% of the portfolio, ranked #22.

Quadrant Capital Group first reported a position in LLY in Q2 2015 and has held it in 44 quarters since. The position peaked at $23.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Quadrant Capital Group held 22,510 shares of Eli Lilly worth $20.7M as of Q1 2026.
  • Quadrant Capital Group bought 748 Eli Lilly shares in Q1 2026, an estimated $758K.
  • Eli Lilly made up 0.62% of Quadrant Capital Group's portfolio in Q1 2026, its #22 holding.
  • Quadrant Capital Group first reported a position in Eli Lilly in Q2 2015 and has held it in 44 quarters since.
  • Quadrant Capital Group's Eli Lilly position peaked at $23.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.